Sarafloxacin (CAS 98105-99-8) — formula C20H17F2N3O3, molecular weight 385.4; category organic chemicals.
| CAS Number | 98105-99-8 |
|---|---|
| Molecular Formula | C20H17F2N3O3 |
| Molecular Weight | 385.4 |
| LogP | 0.3 |
| Applications | Uses: MEDICATION (VET), Use Classification: Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes, Pharmaceuticals, Methods of Manufacturing: Condensation of 7-chloro-1-(p-fluorophenyl)-6-fluoro-1, 4-dihydro-4-oxoquinoline-3-carboxylic acid with N-carboethoxypiperazine in hot 1-methyl-2-pyrrolidinone yields the N-carboethoxy derivative of A-56620. Hydrolysis of the derivative with sodium hydroxide in aqueous ethanol followed by treatment with dilute hydrochloric acid gives A-56620., Preparation: D. T. W. Chu, European Patent Office patent 131839, idem, USA patent 4730000 (1985, 1988 both to Abbott), ... H. Narita et al., Japanese patent Kokai 85237069 (1985 to Toyama)., General Manufacturing Information: Patent number U.S. 4, 730, 000, expired, March 18, 2005, Sarafloxacin hydrchloride injection |
| Category | Organic Chemicals |
Documented applications: Uses: MEDICATION (VET), Use Classification: Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes, Pharmaceuticals, Methods of Manufacturing: Condensation of 7-chloro-1-(p-fluorophenyl)-6-fluoro-1, 4-dihydro-4-oxoquinoline-3-carboxylic acid with N-carboethoxypiperazine in hot 1-methyl-2-pyrrolidinone yields the N-carboethoxy derivative of A-56620. Hydrolysis of the derivative with sodium hydroxide in aqueous ethanol followed by treatment with dilute hydrochloric acid gives A-56620., Preparation: D. T. W. Chu, European Patent Office patent 131839, idem, USA patent 4730000 (1985, 1988 both to Abbott), ... H. Narita et al., Japanese patent Kokai 85237069 (1985 to Toyama)., General Manufacturing Information: Patent number U.S. 4, 730, 000, expired, March 18, 2005, Sarafloxacin hydrchloride injection.
Sarafloxacin is a carbon-based organic compound with CAS registry number 98105-99-8 and molecular formula C20H17F2N3O3 (molecular weight 385.4), belonging to the organic chemicals segment of chemical raw materials.
CAS number: 98105-99-8
Its molecular formula C20H17F2N3O3 comprises 20 C, 17 H, 2 F, 3 N, 3 O atoms.
Also known as: Sarafloxacin · 沙拉沙星
Category: organic chemicals
The CAS registry number of Sarafloxacin is 98105-99-8.
Molecular formula C20H17F2N3O3, molecular weight 385.4.
It is also registered under: Sarafloxacin, 沙拉沙星.
Recorded applications: Uses: MEDICATION (VET), Use Classification: Veterinary Drug -> ANTIMICROBIAL_AGENT -> JECFA Functional Classes, Pharmaceuticals, Methods of Manufacturing: Condensation of 7-chloro-1-(p-fluorophenyl)-6-fluoro-1, 4-dihydro-4-oxoquinoline-3-carboxylic acid with N-carboethoxypiperazine in hot 1-methyl-2-pyrrolidinone yields the N-carboethoxy derivative of A-56620. Hydrolysis of the derivative with sodium hydroxide in aqueous ethanol followed by treatment with dilute hydrochloric acid gives A-56620., Preparation: D. T. W. Chu, European Patent Office patent 131839, idem, USA patent 4730000 (1985, 1988 both to Abbott), ... H. Narita et al., Japanese patent Kokai 85237069 (1985 to Toyama)., General Manufacturing Information: Patent number U.S. 4, 730, 000, expired, March 18, 2005, Sarafloxacin hydrchloride injection.
Category: Organic Chemicals.
Independent reference data for Sarafloxacin (CAS 98105-99-8), compiled from public chemistry databases.
| CAS Registry Number | 98105-99-8 |
|---|---|
| PubChem CID | 56208 |
| Molecular formula | C20H17F2N3O3 |
| IUPAC name | 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid |
| UNII (FDA) | RC3WJ907XY |
| Molecular Weight | 385.4 |
|---|---|
| XLogP3 | 0.3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 3 |
| Exact Mass | 385.12379774 |
| Monoisotopic Mass | 385.12379774 |
| Topological Polar Surface Area | 72.9 |
| Heavy Atom Count | 28 |
| Dissociation Constants | pKa1= 5.6; pKa2 = 8.2 |
|---|---|
| Collision Cross Section | 203.4 Ų [M+Na]+ |
| Collision Cross Section | 187.09 Ų [M+H]+ |
| Collision Cross Section | 202 Ų [M+H]+ |
Sarafloxacin; 98105-99-8; Sarafloxacine; 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid; Sarafloxacino; Sarafloxacinum; Difloxacinum [Latin]; DTXSID8048494; 6-fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid; RC3WJ907XY; ABBOTT-57135; 3-Quinolinecarboxylic acid, 6-fluoro-1-(4-fluorophenyl)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-; A-56620; DTXCID4028468; Difloxacinum (Latin); 1-FPFPOC
| Regulatory & Food Contact | ANTIMICROBIAL_AGENT: Veterinary Drug 0-0.33 µg/kg bw TRS 888-JECFA 50/33 FAS 41-JECFA 50/37 |
|---|---|
| GHS notification summary | 100% (3 / 3) |
| GHS notification summary | 100% (3 / 3) |
|---|
This chemical does not meet GHS hazard criteria for 100% (3 of 3) of all reports.
Reported as not meeting GHS hazard criteria by 3 of 3 companies. For more detailed information, please visit ECHA C&L website.
Sarafloxacin · CAS 98105-99-8 · C20H17F2N3O3. UNII RC3WJ907XY. Dissociation Constants: pKa1= 5.6; pKa2 = 8.2; Collision Cross Section: 203.4 Ų [M+Na]+; Collision Cross Section: 187.09 Ų [M+H]+.
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.
中文页面: 沙拉沙星